Distinguished in Low Blood Sugar

Sophie Borot

Besancon, FR 
Distinguished in Low Blood Sugar
Besancon, FR 
OverviewLocationsClinical Research

Overview

Sophie Borot practices in Besancon, France. Ms. Borot is rated as a Distinguished expert by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Addison's Disease, Islet Cell Transplantation, and Kidney Transplant.

Her clinical research consists of co-authoring 70 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 11 articles in the study of Low Blood Sugar.

Gender
Female

Locations

Besancon, France
Other Locations
Grenoble, France
Angers, France
Alsace
Strasbourg, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Enrollment Status: Terminated
Publish Date: April 09, 2025
Intervention Type: Other
Study Phase: Not Applicable
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)
Enrollment Status: Completed
Publish Date: July 08, 2024
Intervention Type: Device
ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes
ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Device, Other
Study Phase: Not Applicable
Health Economic Analysis of Islet Cell Transplantation for Patients With Severe Forms of Brittle Type 1 Diabetes
Health Economic Analysis of Islet Cell Transplantation for Patients With Severe Forms of Brittle Type 1 Diabetes
Enrollment Status: Unknown
Publish Date: June 24, 2022
Intervention Type: Drug, Procedure
Study Drug: Best Medical Care
Study Phase: Phase 3
Multicentre Randomized Cross-over Study Assessing in Type 1 Diabetic Patients With Pump Insulin the Non-inferiority of Glycemic Control Obtained With the Algorithms Tested in DIABRASPORT Versus the Rest Period Without Physical Activity
Multicentre Randomized Cross-over Study Assessing in Type 1 Diabetic Patients With Pump Insulin the Non-inferiority of Glycemic Control Obtained With the Algorithms Tested in DIABRASPORT Versus the Rest Period Without Physical Activity
Enrollment Status: Completed
Publish Date: April 08, 2021
Intervention Type: Device, Behavioral
Study Phase: Not Applicable
Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes
Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 21, 2020
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Enrollment Status: Completed
Publish Date: August 21, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

70 Total Publications

Use of the Glycemia Risk Index at Hybrid Closed-Loop Initiation to Predict Combined International Glucose Targets at 12 Months: Results From the CIRDIA Study Group.
Use of the Glycemia Risk Index at Hybrid Closed-Loop Initiation to Predict Combined International Glucose Targets at 12 Months: Results From the CIRDIA Study Group.
Journal: Journal of diabetes science and technology
Published: October 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Borot's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile